A Histological Study Evaluating Silk Voice and Crosslinked Hyaluronic Acid
Sponsor: Sofregen Medical, Inc.
Listed as NCT04315415, this NA trial focuses on Vocal Cord Atrophy and Vocal Cord Paralysis and remains completed. Sponsored by Sofregen Medical, Inc., it has been updated 6 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
May 2022 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Mar 2021 — May 2022 [monthly]
Active Not Recruiting NA
-
Jan 2021 — Mar 2021 [monthly]
Active Not Recruiting NA
▶ Show 1 earlier version
-
Apr 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
First recorded
Jan 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Sofregen Medical, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .